+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Syncope"

Syncope - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Syncope - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Geriatric Neurology. Edition No. 1 - Product Thumbnail Image

Geriatric Neurology. Edition No. 1

  • Book
  • April 2014
  • 744 Pages
Encyclopedia of Heart Diseases - Product Thumbnail Image

Encyclopedia of Heart Diseases

  • Book
  • December 2005
Cardiology Secrets. Edition No. 6 - Product Thumbnail Image

Cardiology Secrets. Edition No. 6

  • Book
  • February 2022
Loading Indicator

Syncope is a type of Central Nervous System (CNS) drug used to treat a variety of conditions, including seizures, anxiety, and depression. It is a type of anticonvulsant, meaning it works by blocking certain nerve signals in the brain. It is also used to treat certain types of headaches, such as migraines. Syncope is typically prescribed in combination with other medications, such as antidepressants or anticonvulsants. The Syncope market is a rapidly growing segment of the CNS drug market. It is estimated that the market will continue to grow in the coming years, driven by increasing demand for CNS drugs and the development of new treatments. Additionally, the increasing prevalence of mental health disorders is expected to drive the growth of the Syncope market. Some of the major players in the Syncope market include Pfizer, GlaxoSmithKline, Johnson & Johnson, Novartis, and Sanofi. These companies are actively involved in the development and marketing of Syncope drugs. Additionally, there are several smaller companies that are involved in the development and marketing of Syncope drugs. Show Less Read more